BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24246415)

  • 1. Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.
    Sato Y; Ishida H; Shimizu T; Tanabe K
    Transpl Immunol; 2014 Jan; 30(1):12-7. PubMed ID: 24246415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.
    Von Visger JR; Gunay Y; Andreoni KA; Bhatt UY; Nori US; Pesavento TE; Elkhammas EA; Winters HA; Nadasdy T; Singh N
    Clin Transplant; 2014 Aug; 28(8):845-54. PubMed ID: 24869763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB; Hoitsma AJ; Assmann KJ; Wetzels JF
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G; Longhi S; Quaglini S; Gallelli B; Banfi G; Montagnino G; Messa P
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F; Gelpi R; Koskinen P; Manonelles A; Räisänen-Sokolowski A; Carrera M; Honkanen E; Grinyó JM; Cruzado JM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tonsillectomy for patients with recurrence of IgA nephropathy after kidney transplantation.
    Ushigome H; Suzuki T; Fujiki M; Nobori S; Sakamoto S; Okamoto M; Urasaki K; Yoshimura N
    Clin Transplant; 2009 Aug; 23 Suppl 20():17-22. PubMed ID: 19594590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
    Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
    Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsillectomy ameliorates histological damage of recurrent immunoglobulin A nephropathy after kidney transplantation.
    Hotta K; Fukasawa Y; Akimoto M; Tanabe T; Sasaki H; Fukuzawa N; Seki T; Togashi M; Harada H
    Nephrology (Carlton); 2013 Dec; 18(12):808-12. PubMed ID: 23941658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
    Sugawara K; Takeda K; Nakai K; Takahashi N; Adachi T; Fukuda T; Miura S
    Nihon Jinzo Gakkai Shi; 2008; 50(8):1017-23. PubMed ID: 19172803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recurrence of active IgA nephropathy after kidney transplantation.
    Otsuka Y; Takeda A; Horike K; Inaguma D; Goto N; Watarai Y; Morozumi K
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():45-8. PubMed ID: 24842823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    Lionaki S; Makropoulos I; Panagiotellis K; Vlachopanos G; Gavalas I; Marinaki S; Liapis G; Michelakis I; Bokos I; Boletis I
    PLoS One; 2021; 16(8):e0253337. PubMed ID: 34403416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of tonsillectomy in renal transplant patients with recurrent IgA nephropathy].
    Zhu L; Feng H; Jia JD; Peng S; Li YQ; Shao JF; He XF; Guan Y; Guo H; Lin ZB; Chen G
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(3):176-180. PubMed ID: 29374910
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation.
    Yaginuma T; Yamamoto H; Mitome J; Kobayashi A; Yamamoto I; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Miki J; Yamada H; Furuta N; Yamaguchi Y; Hosoya T
    Clin Transplant; 2011 Jul; 25 Suppl 23():28-33. PubMed ID: 21623911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation.
    Katsumata H; Yamamoto I; Komatsuzaki Y; Kawabe M; Okabayashi Y; Yamakawa T; Katsuma A; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    BMC Nephrol; 2018 Mar; 19(1):64. PubMed ID: 29540152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible kidney transplantation: first cases in Turkey.
    Tuncer M; Yücetin L; Tekin S; Demirbas A
    Transplant Proc; 2012; 44(6):1703-5. PubMed ID: 22841248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.
    Di Vico MC; Messina M; Fop F; Barreca A; Segoloni GP; Biancone L
    Clin Transplant; 2018 Apr; 32(4):e13207. PubMed ID: 29345747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.